RebiSmart™

DEVICE2 trials

Sponsors

EMD Serono, Merck KGaA, Darmstadt, Germany

Conditions

MSMultiple Sclerosis

Phase 3

A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study

CompletedNCT01036165

EMD SeronoMultiple Sclerosis

Start: 2010-01-31End: 2010-08-31Updated: 2013-08-08

Unknown Phase

Treatment Adherence When Using RebiSmart™ in Relapsing Multiple Sclerosis Subjects

CompletedNCT01128075

Merck KGaA, Darmstadt, GermanyMS, Multiple Sclerosis

Start: 2009-08-31End: 2014-04-30Updated: 2014-07-09

Related Papers

Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study

BMC Research Notes2016-03-0816 citations

Relationship between Cognitive Status and Perception of Ease of Use of an Electronic Autoinjector for Subcutaneous Interferon Beta-1a (P3.225)

Neurology2015-04-06